Journal Articles

2021

• Robinson AB, Ali N, Costa O, Rooks-Peck C, Sorensen-Alawad A, Ballard J, Lowerre K, Fondario A. A Thematic Analysis of Overdose Prevention and Response Efforts in States Experiencing Declines in Rates of Opioid-Involved Overdose Deaths.external icon Public Health Rep. 2021. doi: 10.1177/00333549211026816.
• Compton, WM, Jones CM. Substance Use among Men Who Have Sex with Men.external icon NEJM. (385)4: 352-356. 2021. doi: 10.1056/NEJMra2033007.
• Vivolo-Kantor AM, Smith H, Scholl L. Differences and similarities between emergency department syndromic surveillance and hospital discharge data for nonfatal drug overdose.external icon Annals of Epidemiology. 2021.ISSN 1047-2797. doi: 10.1016/j.annepidem.2021.05.008.
• Goldstick JE, Guy GP, Losby JL, Baldwin G, Myers M, Bohnert ASB. Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain.external icon JAMA. 2021;4(7):e2116860. doi:10.1001/jamanetworkopen.2021.16860
• Underwood N, Rooks-Peck C, Ali N, Wisdom A, Costa O, Robinson A, Mells J and Bacon S. State-led opioid overdose prevention efforts: Challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS).external icon Substance Abuse. 2021. doi: 10.1080/08897077.2021.1903649
• Cruz K, Deokar A, Feldman SJ, Patrick H. Special Report from the CDC: Readiness to surge: State health departments’ workforce infrastructure during the opioid crisis.external icon J Safety Res. 2021; 77: 324-327. doi: 10.1016/j.jsr.2021.03.012.
• Vivolo-Kantor, A, Pasalic E, Liu S, Martinez PD, Gladden RM. Defining indicators for drug overdose emergency department visits and hospitalisations in ICD-10-CM coded discharge dataexternal icon. Injury Prevention. 2021; 27 (S1): i56-i61. http://dx.doi.org/10.1136/injuryprev-2019-043521external icon
• Baldwin GT, Seth P, Noonan RK. Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practiceexternal icon. JAMA. Published online February 11, 2021. doi:10.1001/jama.2021.1169

• Holland KM, Jones C, Vivolo-Kantor AM, et. al. Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence-Related Outcomes Before and During the COVID-19 Pandemicexternal icon. JAMA Psychiatry. 2021, Feb 3. doi:10.1001/jamapsychiatry.2020.4402

• Jones CM, Guy GP, Board A. Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020.external icon Drug and Alcohol Dependence. 2021, Feb 1. 219(2021). doi: 10.1016/j.drugalcdep.2020.108486

2020

• Roehler DR, Olsen EO, Mustaquim D, Vivolo-Kantor AM. Roehler D, Olsen E, Mustaquim D, Vivolo-Kantor D. Suspected nonfatal opioid and other drug-related overdoses among youth in the US, 2016-2019.external icon Pediatrics. 2020, Dec 14. 2021;147(1). doi: 10.1542, 2020.003491
• Florence C, Luo F, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017.external icon Drug and Alcohol Dependence. 2020, Oct 27. doi: 10.1016/j.drugalcdep.2020.108350
• Board AR, Guy GP, Jones CM, Hoots B. Trends in Stimulant Dispensing by Age, Sex, State of Residence, and Prescriber Specialty — United States, 2014–2019.external icon Drug and Alcohol Dependence. 2020, Sep 15. doi: 10.1016/j.drugalcdep.2020.108297
• Strahan AE, McKenna C, Miller GF, Guy GP. Prevalence of Nonpharmacologic and Pharmacologic Therapies Among Noncancer Chronic Pain–Associated Ambulatory Care Visits, 2016.external icon American Journal of Preventive Medicine. 2020, Aug 22.  doi: 10.1016/j.amepre.2020.04.02
• Mital S, Wolff J, Carroll JJ, The relationship between incarceration history and overdose in North America: A scoping review of the evidence.external icon Drug and Alcohol Dependence. 2020, May 24. 213:108088. doi: 10.1016/j.drugalcdep.2020.108088
• Roehler DR, Guy GP Jr, Jones CM. Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study.external icon Drug and Alcohol Dependence. 2020, May 25. 213:108083. doi: 10.1016/j.drugalcdep.2020.108083
• Mikosz CA, Zhang K, Haegerich T, Xu L, Losby JL, Greenspan A, Baldwin G, Dowell D. Indication-Specific Opioid Prescribing for US Patients with Medicaid or Private Insurance, 2017.external icon JAMA  Network Open. 2020, May 11. 3(5):e204514. doi: 10.1001/jamanetworkopen.2020.4514
• Jones CM, Olsen EO, ODonnell J, Mustaquim D. Resurgent Methamphetamine Use At Treatment Admission in the United States, 2008-2017.external icon American Journal of Public Health. 2020, March 11. 110, 509-516. doi: 10.2105/AJPH.2019.305527
• Hoots B, Vivolo-Kantor A, Seth P. The rise in nonfatal and fatal overdoses involving stimulants with and without opioids in the United States.external icon Addiction. Epub 2020, Jan 7. doi: 10.1111/add.14878

2019

• Haegerich T, Jones C, Cote PO, Robinson A, Ross L. Evidence for State, Community and Systems-Level Prevention Strategies to Address the Opioid Crisisexternal icon. Drug and Alcohol Dependence. 2019; doi:10.1016/j.drugalcdep.2019.107563
• Guy G, Zhang K, Halpin J, Sargent W. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in Nine States, 2015external icon. American Journal of Preventive Medicine. doi:10.1016/j.amepre.2019.06.007
• Houry, D, Adams, J. Emergency Physicians and Opioid Overdoses: A Call to Aidexternal icon. Annals of Emergency Medicine, doi: 10.1016/j.annemergmed.2019.07.020
• Jones C, Compton W, Vythilingam M. Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017external icon. JAMA Network. 2019;322(5):462-464. doi: 10.1001/jama.2019.7988
• Bohm M, Bridwell L, Zibbell J, Zhang K. Heroin and Healthcare: Patient Characteristics and Healthcare Prior to Overdoseexternal icon. The American Journal of Managed Care. 2019;26(7):341-347.
• Vivolo-Kantor A, Hoots B, David F, Gladden R. Suspected Heroin Overdose in U.S. Emergency Departments, 2017-2018external icon. American Journal of Public Health, July 2019; 109(7): 1022-1024. doi:10.2105/AJPH.2019.305053
• Dowell D, Haegerich T, Chou R. No Shortcuts to Safer Opioid Prescribingexternal icon. New England Journal of Medicine. 2019;380:2285-2287. doi: 10.1056/NEJMp1904190
• Baird J, Faul M, Green T, Howland J, Adams C, Hodne M, Bohlen N, Mello M. Evaluation of a Safer Opioid Prescribing Protocol (SOPP) for Patients Being Discharged From a Trauma Serviceexternal icon. Journal of Trauma Nursing, May/June 2019; 26(3):113–120. doi:10.1097/JTN.0000000000000435
• Coffey W, Hunter A, Mobley E, Vivolo-Kantor A. Rural-Urban Trends in Opioid Overdose Discharges in Missouri Emergency Departments, 2012-2016external icon. The Journal of Rural Health, 2019 Apr 25: 1-10. doi: 10.1111/jrh.12368.
• Nataraj N, Zhang K, Guy G, Losby J. Identifying opioid prescribing patterns for high-volume prescribers via cluster analysisexternal icon. Drug and Alcohol Dependence, doi: 10.1016/j.drugalcdep.2019.01.012
• Schieber L, Guy G, Seth P, Young R, Mattson C, Mikosz C, Schieber R.  Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by States, United States, 2006-2017external iconexternal icon. JAMA Network Open. 2019;2(3):e190665. Doi:10.1001/jamanetworkopen.2019.0665
• Guy G, Zhang K, Schieber L, Young R, Dowell D. County-level Opioid Prescribing in the United States, 2015 and 2017external iconexternal icon. JAMA Internal Med. Published online February 11, 2019; doi:10.1001/jamainternmed.2018.6989

2018

• Guy G, Zhang K. Opioid Prescribing by Specialty and Volume in the U.Sexternal icon. AJPM. Published online October 5, 2018. DOI: j.amepre.2018.06.008
• Bohnert A, Guy G, Losby J.  Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention’s 2016 Opioid Guidanceexternal icon. Ann Intern Med. 2018; 169(6):367-375. doi: 10.7326/M18-1243
• Lin DH, Jones CM, Compton WM, et. al. Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.external icon JAMA Network Open. 2018; 1(2), e180235. doi:10.1001/jamanetworkopen.2018.0235
• Johnson K, Jones C, Wilson C, et al. Federal Response to the Opioid Crisisexternal icon. Current HIV/AIDS Report. 2018; 15:293–301. doi: 10.1007/s11904-018-0398-8
• Seth P, Rudd R, Noonan, R, Haegerich, T. Quantifying the Epidemic of Prescription Opioid Overdose Deathsexternal icon. AJPH, 2018; 108(4),e1-e3. doi: 10.2105/AJPH.2017.304265
• Houry DE, Haegerich TM, Vivolo-Kantor A. Opportunities for Prevention and Intervention of Opioid Overdose in the Emergency Department.external icon Ann Emerg Med. 2018; 108 (4) 500-502. doi: 10.1016/j.annemergmed.2018.01.052.
• Mercado MC, Sumner SA, Spelke MB, Bohm MK, Sugerman DE, Stanley C. Increase in Drug Overdose Deaths Involving Fentanyl—Rhode Island, January 2012–March 2014external icon. Pain Med. 2018; 19(3):511-523. doi: 10.1093/pm/pnx015.

2017

• Guy G, Pasalic E, Zhang K. Emergency department visits involving opioid overdoses – United States, 2010-2014external icon. AJPM. 2017; 54 (1) 37-39. doi: j.amepre.2017.09.003
• Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deathsexternal icon. JAMA. 2017;318(23):2295-2296. doi:10.1001/jama.2017.15971
• Dowell D, Arias E, Kochanek K, Anderson R, Guy GP, Losby J, Baldwin G. Contribution of Opioid-Involved Poisoning to the Change in Life Expectancy in the United States, 2000-2015external icon. JAMA. 2017;3 18(11):1065-1067. doi10.1001/jama.2017.9308
• Dowell D, Haegerich TM. Changing the Conversation About Opioid Taperingexternal icon. Ann Intern Med. 2017;167(3):208-209. doi: 10.7326/M17-1402.
• Losby JL, Hyatt JD, Kanter MH, Baldwin G, Matsuoka D. Safer and more appropriate opioid prescribing: a large healthcare system’s comprehensive approachexternal icon. J Eval Clin Pract. 2017;1–7. doi: 10.1111/jep.12756.
• Schuchat A, Houry DE, Gery Jr GP. New data on opioid use and prescribing in the United Statesexternal icon. JAMA 2017; 318(7):1-2. doi:10.1001/jama.2017.8913
• Baird J, Faul M, Green TC, Howland J, Adams CA, George A, Mello MJ. A retrospective review of unintentional opioid overdose risk and mitigating factors among acutely injured trauma patientsexternal icon. Drug and Alcohol Dependence. 2017; 178:130-135. doi: 10.1016/j.drugalcdep.2017.04.030.
• Faul M, Lurie P, Kinsman JM, Dailey MW, Crabaugh C, Sasser SM. Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasingexternal icon. Prehosp Emerge Care.2017; 21(4): 411-419. doi: 10.1080/10903127.2017.1315203.
• Jones CM, Baldwin GT, Compton WM. Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioidsexternal icon. AJPH. 2017; 107( 3):430-432. doi: 10.2105/AJPH.2016.303627.

2016

• Dowell D, Zhang K, Noonan RK, Hockenberry JM. Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death ratesexternal icon. Health Aff .2016; 35(10):1-9. doi: 10.1377/hlthaff.2016.0448
• Neven D, Paulozzi L, Howell D, McPherson S, Murphy SM, Grohs B, Marsh L, Lederhos C, Roll J. A Randomized Controlled Trial of a Citywide Emergency Department Care Coordination Program to Reduce Prescription Opioid Related Emergency Department Visitsexternal icon. J Emerg Med51(5) 498-507. doi: 10.1016/j.jemermed.2016.06.057.
• Florence CS, Zhou C, Luo F, Xu L. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013external icon. Med Care.2016; 54(10): 901-906. doi:10.1097/MLR.0000000000000625
• Easterling KW, Mack KA, Jones CM. Location of fatal prescription opioid-related deaths in 12 states, 2008-2010: Implications for prevention programsexternal icon. J Safety Res. 2016; 58:105-109. doi: 10.1016/j. jsr.2016.07.004
• Kattan JA, Tuazon E, Paone D, Dowell D, Vo L, Starrels JL, Jones CM, Kunins HV.  Public Health Detailing—A Successful Strategy to Promote Judicious Opioid Analgesic Prescribingexternal icon. AJPH. 2016; 106(8), 1430-1438. doi: 10.2105/AJPH.2016.303274.
• Chang HY, Lyapustina T, Rutkow L, Daubresse M, Richey M, Faul M, Stuart EA, Alexander GC. Impact of prescription drug monitoring programs and pill mill laws on high-volume opioid prescribers: A comparative interrupted time series analysisexternal icon. Drug Alcohol Depend. 2016; 165, 1-8. doi: 10.1016/j.drugalcdep.2016.04.033.
• Zhou, C, Florence, C, Dowell, D. Payments For Opioids Shifted Substantially To Public And Private Insurers While Consumer Spending Declined, 1999–2012external icon. Health Aff. 2016; 35(5): 824-831. doi:10.1377/hlthaff.2015.1103.
• Sumner SA, Mercado-Crespo MC, Spelke MB, Paulozzi LJ, Sugerman DE, Hillis SD, Stanley C. Use of naloxone by emergency medical services during opioid drug overdose resuscitation effortsexternal icon. Prehosp Emerg Care. 2016; 20(2):220-225. doi:10.3109/10903127.2015.1076096.
• Frieden TR, Houry D. Reducing the risks of relief — the CDC opioid-prescribing guidelineexternal icon. N Engl J Med. 2016. 374: 1501-1504. doi:10.1056/NEJMp1515917.
• Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016external icon; JAMA, Special Communication. Published online March 15, 2016. doi: 1001/jama.2016.1464external icon.
• Scott LC, Lewis S. Opioids for Chronic Painexternal icon. JAMA Patient Page.; 315(15), 1672. doi:10.1001/jama.2016.3224.
• Paulozzi LJ, Zhou C, Jones CM, Xu L, Florence CS. Changes in the medical management of patients on opioid analgesics following a diagnosis of substance abuseexternal icon. Pharmacoepidemiol Drug Saf.2016; (5)545-52. doi:10.1002/pds.3980.
• Compton WM, Jones CM, Baldwin GT, Relationship between Nonmedical Prescription-Opioid Use and Heroin Useexternal icon. NEJM. 2016; 374:154-163. doi:10.1056/NEJMra1508490.
• Lyapustina T, Rutkow L, Chang H, Daubresse M, Ramji AF, Faul M, Stuart EA, and Alexander GC. Effect of a “pill mill” law on opioid prescribing and utilization: The case of Texas.external icon Drug Alcohol Depen. 2016; 159 (1) 109-197. doi:10.1016/j.drugalcdep.2015.12.025.

2015

• Fulton-Kehoe D, Sullivan MD, Turner JA, Garg RK, Bauer AM, Wickizer TM, Franklin GM. Opioid Poisonings in Washington State Medicaidexternal icon. Med Care. 2015; 53 (8), 679 doi:10.1097/MLR.0000000000000384.
• Jones C, Campopiano M, Baldwin G, McCance-Katz E. (2015). National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatmentexternal icon. 2015; 105, (8), 55-63. doi:10.2105/AJPH.2015.302664.
• Faul M, Dailey MW, Sugerman DE, Sasser SM, Levy B, Paulozzi LJ. (2015). Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communitiesexternal icon. AJPH, 2015; 105 (3), 26-32. doi:10.2105/AJPH.2014.302520.
• Mack KA, Zhang K, Paulozzi L, Jones C. Prescription Practices involving Opioid Analgesics among Americans with Medicaid, 2010external icon. J Health Care Poor Underserved. 2015;26(1):182-98. doi: 1353/hpu.2015.0009

2014

• Haegerich TM, Paulozzi L, Manns B, Jones CJ. What we know and don’t know about state and system level policy strategies to prevent prescription drug overdoseexternal icon. Drug Alcohol Depen.2014; 145: 34-37. doi: 10.1016/j.drugalcdep.2014.10.001.
• Jones C, Paulozzi L, Mack K. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use: United States, 2008–2011.external icon JAMA Int Med. 2014; 174(5):802-803. doi:1001/jamainternmed.2013.12809external icon
• Baumblatt JA, Wiedeman C, Dunn J, Schaffner W, Paulozzi L, Jones T. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.external icon JAMA Int Med. 2014; 174 (5):796-801. doi:10.1001/jamainternmed.2013.12711
• Paulozzi L, Zhang K, Jones C, Mack K. Risk of adverse health outcomes with increasing duration and regularity of opioid therapy.external icon J Am Board Fam Med. 2014; 27 (3): 329-338.doi: 3122/jabfm.2014.03.130290

2013

• Sauber-Schatz EK, Mack KA, Diekman ST, Paulozzi LJ, Associations between pain clinic density and distributions of opioid pain relievers, drug-related deaths, hospitalizations, emergency department visits and neonatal abstinence syndrome in Floridaexternal icon. Drug Alc Depend. 2013; 133 (1) 161-166. http://dx.doi.org/10.1016/j.drugalcdep.2013.05.017external icon.
• Logan J, Liu Y, Paulozzi LJ, Zhang K, Jones C. Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse.external icon Med Care. 2013; 51 (8).doi:10.1097.
• Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002-2004 and 2008-2010.external icon Drug Alc Depend. 2013; 132 (1-2): 95-100 Available at: http://dx.doi.org/10.1016/j.drugalcdep.2013.01.007external icon.
• Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010external icon. 2013; 309(7):657-659. doi:10.1001/jama.2013.272

2012

• Paulozzi LJ. Prescription drug overdoses: a review.external icon J Safety Res. 2012; 43(4): 283-289. org/10.1016/j.jsr.2012.08.009external icon
• Jones C. Frequency of prescription pain reliever nonmedical use: 2002-2003 and 2009-2010external icon. Arch Intern Med.2012;172(16):1265- doi:10.1001/archinternmed.2012.2533
• Kenan K, Mack K, Paulozzi LJ. Open Med. 2012; 6(2)e41- doi:PMC3659213
• Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG, Harvey W, Loring LD. A history of being prescribed controlled substances and risk of drug overdose death.external icon Pain Med. 2012; 13 (1):87-95. https://doi.org/10.1111/j.1526-4637.2011.01260.xexternal icon

2011

• Paulozzi LJ, Weisler RH, Patkar AA. A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control Itexternal icon. J Clin Psychiatry. 2011; 72(5):589-592.
• Paulozzi L, Kilbourne E, Desai H. Prescription drug monitoring programs and death rates from drug overdose.external icon Pain Med. 2011;12:747-754. doi:1111/j.1526-4637.2011.01062.xexternal icon
• Toblin R, Mack K, Perveen G, Paulozzi L. .A population-based survey of chronic pain and its treatment with prescription drugs. Pain.external icon 2011; 152(6):1249-55. org/10.1016/j.pain.2010.12.036external icon

2006 – 2010

• Paulozzi LJ, Stier, DD. Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania.external icon J Pub Health Policy. 2010; 31422-432. https://doi.org/10.1057/jphp.2010.27
• Toblin RL, Paulozzi LJ, Logan JE, Hall AJ, Kaplan JA.  Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review J Clin Psych. 2010;71: 491-496.
• Paulozzi LJ, Logan JE, Hall AJ, McKinstry E, Kaplan JA. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia.external icon Addiction. 2009; 104 (9):1541-1548. https://doi.org/10.1111/j.1360-0443.2009.02650.xexternal icon
• Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE, Paulozzi LJ. Patterns of abuse among unintentional pharmaceutical overdose fatalities.external icon JAMA 2008; 300(22):2613-2620.
• Paulozzi LJ, Xi L. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug typeexternal icon. Pharmacoepidemiol Drug Saf. 2008;17(10): 997-1005. https://doi.org/10.1002/pds.1626external icon
• Paulozzi LJ, Annest J. US data show sharply rising drug-induced death rates.external icon Injury Prevention. 2007;13 (2):130-132. http://dx.doi.org/10.1136/ip.2006.014357external icon
• Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States.external icon Pharmacoepidemiol and Drug Saf. 2006; 15: 618-627. doi: 10.1002/pds.1276
• Paulozzi LJ,Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United Statesexternal icon. Am J Prev Med. 2006; 31 (6):506–11. https://doi.org/10.1016/j.amepre.2006.08.017external icon
• Paulozzi LJ. Opioid analgesic involvement in drug abuse deaths in the American metropolitan areasexternal icon. AJPH. 2006; 96 (10):1755-1757. doi:10.2105/AJPH.2005.071647
• Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United Statesexternal icon. Pharmacoepidemiol and Drug Saf. 2006; 15 (9):618-627. org/10.1002/pds.1276external icon